Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2360 (LINC02360) is a human long intergenic non-coding RNA (lincRNA), a type of RNA gene that does not encode a protein and is located in genomic regions not overlapping with known protein-coding genes[1][3][7]. LincRNAs, including LINC02360, are generally over 200 nucleotides in length and are transcribed autonomously[7][5]. They have diverse roles in regulating the expression of neighboring and distant genes, potentially by mechanisms such as chromatin remodeling, modulation of transcriptional activity, RNA stabilization, and acting as enhancers for gene expression, though many specific lincRNAs—including LINC02360—are minimally characterized and their precise functions in human biology and disease remain unclear[5][7][9]. There are no current reports of LINC02360’s involvement in major diseases, no known drug interactions, and it is not regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2360 (LINC02360).